XML 37 R26.htm IDEA: XBRL DOCUMENT v3.20.2
STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION (Tables)
 9 Months Ended
Sep. 26, 2020
Equity [Abstract]  
SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY

Restricted stock activity was as follows:

 

SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY 

          Weighted Average  
    Shares     Grant Fair Value  
Balance, December 28, 2019     1,863,124     $ 1.60  
Granted     628,000       0.54  
Forfeited     (34,500)       2.32  
Vested     (60,000)       1.12  
Balance, September 26, 2020     2,396,624     $ 1.32  
SCHEDULE OF SHARE-BASED PAYMENT AWARD, EMPLOYEE STOCK PURCHASE PLAN, VALUATION ASSUMPTIONS

   For the three months ended September 26, 2020 
Performance price target  $5.25   $6.00   $7.00 
Expected volatility   48.3%   48.3%   48.3%
Interest rate   1.97%   1.97%   1.97%
Expected Life (years)   3    3    3 
Dividend yield   —%    —%    —% 
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE

The following table summarizes stock-based compensation expense within each of the categories below as it relates to non-vested restricted common stock awards for the three and nine months ended September 26, 2020 and September 28, 2019 (no tax benefits were recognized):

 

   Three Months Ended   Nine Months Ended 
   September 26, 2020   September 28,
2019		   September 26, 2020   September 28,
2019		 
Cost of product revenues  $40,620   $18,309   $70,866   $82,524 
Research and development   81,133    73,939    193,788    262,454 
Selling, general and administrative   196,855    359,435    374,096    1,461,021 
Total  $318,608   $451,683   $638,750   $1,805,999